Log in to save to my catalogue

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3904601

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice

About this item

Full title

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2014-02, Vol.124 (2), p.687-695

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

High-dose ionizing irradiation (IR) results in direct tumor cell death and augments tumor-specific immunity, which enhances tumor control both locally and distantly. Unfortunately, local relapses often occur following IR treatment, indicating that IR-induced responses are inadequate to maintain antitumor immunity. Therapeutic blockade of the T cell...

Alternative Titles

Full title

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3904601

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3904601

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI67313

How to access this item